Yosuf Khan
This article presents a prognostic model specifically designed for oral squamous cell carcinoma (OSCC) patients with type 2 diabetes mellitus (T2DM). The coexistence of OSCC and T2DM poses unique challenges for prognosis and treatment, as diabetes can potentially influence tumor behavior and treatment outcomes. The prognostic model incorporates demographic factors, tumor characteristics, diabetes-related factors, and treatment variables to provide a comprehensive assessment of individual patient outcomes. By considering age, gender, race/ethnicity, tumor stage, grade, size, location, lymph node involvement, duration of diabetes, glycemic control, diabetes-related complications, and treatment modalities, the model enables risk stratification, treatment optimization, and informed patient counseling. Further research and validation are needed to refine and optimize the prognostic model, ensuring its effectiveness in guiding personalized treatment decisions and improving outcomes for OSCC patients with T2DM [1].
This article presents a prognostic model specifically designed for oral squamous cell carcinoma (OSCC) patients with type 2 diabetes mellitus (T2DM). The coexistence of OSCC and T2DM poses unique challenges for prognosis and treatment, as diabetes can potentially influence tumor behavior and treatment outcomes. The prognostic model incorporates demographic factors, tumor characteristics, diabetes-related factors, and treatment variables to provide a comprehensive assessment of individual patient outcomes. By considering age, gender, race/ethnicity, tumor stage, grade, size, location, lymph node involvement, duration of diabetes, glycemic control, diabetes-related complications, and treatment modalities, the model enables risk stratification, treatment optimization, and informed patient counseling. Further research and validation are needed to refine and optimize the prognostic model, ensuring its effectiveness in guiding personalized treatment decisions and improving outcomes for OSCC patients with T2DM [1].